4.7 Review

Epigenetic Treatments for Cognitive Impairments

期刊

NEUROPSYCHOPHARMACOLOGY
卷 37, 期 1, 页码 247-260

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2011.85

关键词

learning and memory; neurodegeneration; neuroprotection; drug discovery; development; epigenetics

资金

  1. NINDS
  2. NIMH
  3. NIA
  4. NIDA
  5. Rett Syndrome Foundation
  6. Ellison Medical Foundation
  7. Evelyn F McKnight Brain Research Foundation

向作者/读者索取更多资源

Epigenetic mechanisms integrate signals from diverse intracellular transduction cascades and in turn regulate genetic readout. Accumulating evidence has revealed that these mechanisms are critical components of ongoing physiology and function in the adult nervous system, and are essential for many cognitive processes, including learning and memory. Moreover, a number of psychiatric disorders and syndromes that involve cognitive impairments are associated with altered epigenetic function. In this review, we will examine how epigenetic mechanisms contribute to cognition, consider how changes in these mechanisms may lead to cognitive impairments in a range of disorders and discuss the potential utility of therapeutic treatments that target epigenetic machinery. Finally, we will comment on a number of caveats associated with interpreting epigenetic changes and using epigenetic treatments, and suggest future directions for research in this area that will expand our understanding of the epigenetic changes underlying cognitive disorders. Neuropsychopharmacology Reviews (2012) 37, 247-260; doi: 10.1038/npp.2011.85; published online 18 May 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据